ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists

FORT MYERS, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, has received reaccreditation from the Accreditation Committee of the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida. The recognition follows a recent on-site inspection conducted as part of the CAP’s Accreditation Programs.

Recognized for its rigorous standards and commitment to quality, CAP accreditation helps ensure laboratories operate at the highest levels of accuracy and reliability—contributing to improved patient outcomes and reduced clinical risk.

13516_AON-Lab_Ryan-Olson_Press-Release_Headshot_250722_V1 (1)

“We are pleased to receive reaccreditation from the College of American Pathologists (CAP) for our central laboratory in Fort Myers,” said Dr. Ryan Olson, medical director of pathology. “The AON central laboratory serves community oncology practices across the country, aiding thousands of patients in receiving timely and accurate results to support better treatment decisions. This reaccreditation reflects our team’s dedication to upholding the highest quality standards.”

“Laboratory medicine plays a critical role in modern cancer care,” said Todd Schonherz, chief executive officer of AON. “CAP reaccreditation reflects the high standards we set for patient care across the entire network. I’m proud of our central lab team for maintaining this elite level of quality and helping ensure our community oncology practices have the tools they need to deliver precise, timely care.”

As part of the accreditation process, CAP inspectors review a laboratory’s records, quality control procedures, staff qualifications, equipment facilities, safety practices and overall management. The program is designed to ensure that laboratories meet or exceed the industry’s most current standards and best practices.

In addition to accreditation, the College of American Pathologists supports more than 23,000 laboratories through proficiency testing, quality improvement tools, and best-in-class protocols and guidelines. Built on a foundation of pathologist expertise, the CAP partners with laboratories around the world to drive operational excellence, improve diagnostic confidence and ensure high-quality patient care.

About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, CAP.org and yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/06ecd64e-ea4f-44f2-8e67-6f7885b5d49b


Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.